ClinicalTrialsFinder

Other IDH1-mutated Positive Hematologic Malignancies Clinical Trials in Charleston, South Carolina

1 recruitingCharleston, South Carolina

Showing 1–1 of 1 trials

Recruiting
Phase 1

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

Myelodysplastic SyndromesRelapsed or Refractory Acute Myeloid Leukemia (AML)Untreated AML+1 more
Institut de Recherches Internationales Servier291 enrolled30 locationsNCT02074839